<DOC>
	<DOCNO>NCT01502917</DOCNO>
	<brief_summary>The purpose study test safety new method treat Diffuse Intrinsic Pontine Glioma ( DIPG ) . The researcher use `` convection-enhanced delivery '' ( CED ) deliver agent call 124I-8H9 . CED perform surgery . The study agent infuse small tube place tumor brain . Many study show safely do animal study first time 124I-8H9 give CED human . This one first time CED perform brain stem . 8H9 something call antibody . Antibodies make body fight infection sometimes cancer . The antibody 8H9 produce mice attack many kind tumor . A radioactive substance , 124I , attach 8H9 . 124I-8H9 stick part tumor cell cause tumor cell die radiation . Studies also do human use 124I-8H9 treat kind cancer . Our study DPG relate tumor suggest 8H9 bind tumor , investigators n't know sure . In study , researcher want find safe 124I-8H9 give CED different dose level . They look see effect ( good bad ) patient . The dose 124I-8H9 increase new group patient . The procedure already safely perform low dos infusion volume number patient MSKCC . The amount get depend enter study . If many serious side effect see certain dose , one treat high dose , patient may treat low dose make sure dose safe .</brief_summary>
	<brief_title>Convection-Enhanced Delivery 124I-8H9 Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>Consensus diagnosis must reach multidisciplinary pediatric neurooncology team consider clinical evidence MRI presentation . Tissue diagnosis require . The patient must undergo prior external beam radiotherapy dose 5460 Gy brain stem . At least 4 week 14 week must elapse completion radiotherapy . The patient must adequate general condition study , Lansky Karnofsky Performance Score ≥ 50 study entry . Lansky Performance scale use patient ≤16 year age . The patient must ≥ 2 ≤ 21 year old . Patient must weigh minimum 8 kg . Clinical and/or radiographic ( MRI ) progression tumor follow external beam radiation therapy . Metastatic disease . Untreated symptomatic hydrocephalus determine treat physician . AST ALT &gt; 2x upper limit normal . Platelets &lt; 100,000/mcL . ANC &lt; 1000/mcL . Abnormal PT ( Inr ) &gt; 1.5 INR PTT &gt; 42 sec ( may correct FFP , cryoprecipitate , vitamin K , etc ) . Total bilirubin &gt; 2.0 mg/dl . Serum creatinine &gt; 1.5x upper limit normal age , calculate creatinine clearance nuclear GFR &lt; 70 ml/min/1.73 m2 .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Brain stem glioma</keyword>
	<keyword>CNS</keyword>
	<keyword>MAB 124I-8H9</keyword>
	<keyword>infusion cannula</keyword>
	<keyword>DIPG</keyword>
	<keyword>Diffuse Intrinsic Pontine Glioma</keyword>
	<keyword>11-011</keyword>
</DOC>